Naprelan

Toothache, Chronic Pain, Migraine + 24 more
Treatment
18 FDA approvals
20 Active Studies for Naprelan

What is Naprelan

NaproxenThe Generic name of this drug
Treatment SummaryNaproxen is a pain reliever and anti-inflammatory medication that was first introduced in 1976 as a prescription drug and then approved for over-the-counter use in 1994. It can be used to treat acute pain, rheumatic diseases, and migraines. Naproxen is generally well tolerated and is often prescribed as the first treatment option for pain relief. It is available in immediate and delayed release forms, as well as in combination with other medications (sumatriptan and esomeprazole) to provide additional benefits.
Naprosynis the brand name
image of different drug pills on a surface
Naprelan Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Naprosyn
Naproxen
1976
1260

Approved as Treatment by the FDA

Naproxen, otherwise known as Naprosyn, is approved by the FDA for 18 uses including articular inflammation and Toothache .
articular inflammation
Used to treat articular inflammation in combination with Esomeprazole
Toothache
Juvenile arthritis
Used to treat Juvenile Idiopathic Arthritis (JIA) in combination with Esomeprazole
Inflammation
Used to treat articular inflammation in combination with Esomeprazole
Back
Ankylosing Spondylitis
Used to treat Ankylosing Spondylitis (AS) in combination with Esomeprazole
Dysmenorrhea
Osteoarthritis
Used to treat Osteoarthritis (OA) in combination with Esomeprazole
Osteoarthritis (OA)
Used to treat Osteoarthritis (OA) in combination with Esomeprazole
Rheumatoid Arthritis
Used to treat Rheumatoid Arthritis in combination with Esomeprazole
Headache
Back pain
Migraine
Juvenile Idiopathic Arthritis (JIA)
Used to treat Juvenile Idiopathic Arthritis (JIA) in combination with Esomeprazole
Ankylosing Spondylitis (AS)
Used to treat Ankylosing Spondylitis (AS) in combination with Esomeprazole
Menstrual Distress (Dysmenorrhea)
Fever
Acute Coryza
Used to treat Acute Migraine in combination with Sumatriptan

Effectiveness

How Naprelan Affects PatientsNaproxen is a type of painkiller that reduces inflammation and fever. It works by blocking a certain enzyme (cyclo-oxygenase) that helps produce a type of chemical (prostaglandin) that can cause pain and swelling. While naproxen can effectively reduce pain, it can also lead to an increase in blood pressure and an increased risk of upper gastrointestinal bleeding. Taking other medications such as corticosteroids or anticoagulants at the same time as naproxen can increase the risk of upper gastrointestinal bleeding, as well as having a history of gastrointestinal ulcers.
How Naprelan works in the bodyNaproxen works by blocking two enzymes, COX-1 and COX-2. COX-1 is a normal enzyme found in the stomach lining, while COX-2 is an enzyme that produces prostaglandins involved in pain, fever, and inflammation. By blocking these enzymes, naproxen reduces prostaglandin production, which helps reduce pain, fever, and inflammation. However, it also blocks the COX-1 enzyme, which can cause side effects like gastrointestinal upset and kidney problems.

When to interrupt dosage

The prescribed measure of Naprelan is contingent upon the identified condition, including Menstrual Distress (Dysmenorrhea), Migraine and Toothache. The dosage fluctuates as per the mode of delivery (e.g. Tablet, extended release or Tablet, delayed release) detailed in the table beneath.
Condition
Dosage
Administration
Dysmenorrhea
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Inflammation
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Collagen Diseases
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Migraine
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Sinusitis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Influenza
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Bursitis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Fever
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Tendinopathy
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Arthritis, Gouty
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Rheumatoid Arthritis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Arthritis, Juvenile
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Hay Fever
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Nasal Congestion
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Acute Coryza
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Osteoarthritis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Ankylosing Spondylitis
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Migraine Disorders
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Postoperative Pain
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical
Spasm
125.0 mg/mL, , 220.0 mg, 200.0 mg, 550.0 mg, 275.0 mg, 500.0 mg, 750.0 mg, 375.0 mg, 250.0 mg, 5.0 mg/mg, 125.0 mg, 60.0 mg, 1000.0 mg, 2.2 mg/mg, 1.0 mg/mg, 210.0 mg, 105.0 mg, 50.0 mg/mL, 25.0 mg/mL
Oral, , Suspension, Suspension - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Tablet, Tablet - Oral, Topical, Kit, Kit - Topical, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Capsule, Capsule - Oral, Tablet, coated, Tablet, coated - Oral, Kit - Oral, Rectal, Suppository - Rectal, Suppository, Tablet, extended release, Tablet, extended release - Oral, Cream - Topical, Tablet, for suspension, Tablet, for suspension - Oral, Tablet, multilayer, extended release - Oral, Tablet, multilayer, extended release, Kit - Oral; Topical, Oral; Topical

Warnings

Naprelan has four contraindications and should not be utilized when enduring the conditions in the following table.Naprelan Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Naproxen may interact with Pulse Frequency
Coronary Artery Bypass Grafting
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Naproxen may interact with Pulse Frequency
Severe Hypersensitivity Reactions
Do Not Combine
Naproxen may interact with Pulse Frequency
There are 20 known major drug interactions with Naprelan.
Common Naprelan Drug Interactions
Drug Name
Risk Level
Description
Amiodarone
Major
The metabolism of Amiodarone can be decreased when combined with Naproxen.
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Naproxen.
Cabazitaxel
Major
The metabolism of Cabazitaxel can be decreased when combined with Naproxen.
Enasidenib
Major
The metabolism of Enasidenib can be decreased when combined with Naproxen.
Erlotinib
Major
The metabolism of Erlotinib can be decreased when combined with Naproxen.
Naprelan Toxicity & Overdose RiskNaproxen is available without a prescription, but this increases the chances of an overdose. Generally, the effects of such an overdose are minor, including drowsiness, fatigue, stomach pain, and nausea and vomiting. No specific antidote exists for naproxen overdose, however the symptoms should disappear with proper care. Naproxen should not be taken by pregnant women during their third trimester as it may lead to the early closure of the fetus's ductus arteriosus.

Naprelan Novel Uses: Which Conditions Have a Clinical Trial Featuring Naprelan?

635 active trials are currently underway to investigate the potential of Naprelan to relieve Chronic Pain, Migraine and Juvenile Rheumatoid Arthritis.
Condition
Clinical Trials
Trial Phases
Bursitis
0 Actively Recruiting
Influenza
29 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3
Tendinopathy
0 Actively Recruiting
Postoperative Pain
19 Actively Recruiting
Phase 4, Phase 2, Phase 1, Phase 3, Not Applicable
Inflammation
0 Actively Recruiting
Nasal Congestion
0 Actively Recruiting
Juvenile arthritis
8 Actively Recruiting
Phase 2, Not Applicable, Phase 3
Rheumatoid Arthritis
54 Actively Recruiting
Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1
Spasm
0 Actively Recruiting
Back
7 Actively Recruiting
Not Applicable, Phase 3, Early Phase 1, Phase 1
Fever
2 Actively Recruiting
Not Applicable, Phase 4
Collagen Diseases
0 Actively Recruiting
Osteoarthritis
0 Actively Recruiting
Chronic Pain
130 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1
Migraine
13 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4
Arthritis, Juvenile
1 Actively Recruiting
Not Applicable
Migraine
51 Actively Recruiting
Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1
Arthritis, Gouty
0 Actively Recruiting
Acute Coryza
0 Actively Recruiting
Epilepsy, Post-Traumatic
0 Actively Recruiting

Naprelan Reviews: What are patients saying about Naprelan?

5Patient Review
4/29/2009
Naprelan for Pain
5Patient Review
5/31/2009
Naprelan for Inflammation of the Tendon
5Patient Review
6/11/2009
Naprelan for Rheumatoid Arthritis
5Patient Review
7/5/2011
Naprelan for Pain
One unfortunate side effect is hair loss.
5Patient Review
7/20/2012
Naprelan for Rheumatoid Arthritis
This medication really helped my arthritis. I didn't experience any negative side effects, and only having to take it once a day was great.
4.7Patient Review
7/27/2011
Naprelan for Inflammation of the Tendon
I've had Lyme Disease for 18 years and, as I've gotten older, the joint and muscle pain has become unbearable at times. In 2009, I was prescribed opiates to help with the pain; however, they did not work well for me. This drug is a miracle pill in comparison and doesn't come with the same cardiovascular risks.
4.3Patient Review
4/26/2010
Naprelan for Pain
This pain reliever has been much better for me than oxycoten. I only have to take it once a day, and it's completely effective at keeping the pain and swelling down from my surgery.
4Patient Review
1/12/2010
Naprelan for Pain
3Patient Review
4/21/2011
Naprelan for Rheumatoid Arthritis
More helpful than other over-the-counter options.
3Patient Review
3/14/2013
Naprelan for Inflammation of the Sac Surrounding the Joint - Bursitis
This treatment has been helpful in managing my pain.
2.7Patient Review
6/21/2011
Naprelan for Inflammation of the Sac Surrounding the Joint - Bursitis
While this medication did alleviate the pain I was experiencing, I unfortunately developed a painful rash with blisters. If you experience any similar side effects, make sure to see a doctor right away.
2.3Patient Review
7/1/2011
Naprelan for Painful Periods
This treatment did not alleviate any of the pain I was experiencing from my concussion.
2Patient Review
10/18/2010
Naprelan for Pain
I've been taking this medication for my bunion and it's worked great in terms of healing the physical issue. However, I'm now dealing with a range of uncomfortable side effects like heartburn, nausea, and skin soreness that make the whole experience less than ideal.
1.7Patient Review
2/16/2009
Naprelan for Pain
1Patient Review
10/22/2011
Naprelan for Pain
I was given this medication for my hip pain, but it has done nothing to alleviate the discomfort. It's basically worthless; I would have been better off eating an M&M.

Patient Q&A Section about naprelan

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Naprelan used for?

"NAPRELAN® can be used to treat various forms of arthritis, as well as tendonitis, bursitis, and acute gout. Additionally, it can be used to relieve mild to moderate pain and menstrual cramps."

Answered by AI

How strong of a painkiller is naproxen?

"The naproxen content in each of these varies. The regular naproxen tablets contain 250mg, 375mg, or 500mg of naproxen. The fast-absorbing naproxen sodium is available in 220mg OTC capsules and tablets, and 275mg and 550mg tablets prescribed by a doctor."

Answered by AI

Is Naprelan the same as naproxen?

"NAPRELAN (naproxen sodium) is a nonsteroidal anti-inflammatory drug. It is available in 375 mg, 500 mg, and 750 mg strengths for oral administration."

Answered by AI

How much does Naprelan cost?

"The cost of one hundred Naprelan oral tablets, extended release (375 mg (as sodium)) varies depending on the pharmacy, but is typically around $2,303 for cash paying customers who do not have insurance."

Answered by AI

Clinical Trials for Naprelan

Have you considered Naprelan clinical trials? We made a collection of clinical trials featuring Naprelan, we think they might fit your search criteria.Go to Trials
Image of California Clinical Trials Medical Group in Glendale, United States.

NTR-1011 for Lupus and Rheumatoid Arthritis

18 - 75
All Sexes
Glendale, CA
This phase 1a and 1b study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of NTR-1011 in healthy adults and in adult patients with systemic lupus erythematosus and rheumatoid arthritis. The main goals of this study are to determine the safety profile of NTR-1011 across subcutaneous and intravenous dose levels, understand how the drug behaves in the body, characterize its biological activity through relevant pharmacodynamic markers, assess the potential for immune responses to treatment, and explore early signals of clinical benefit in autoimmune disease settings. This is a randomized, double blind, placebo controlled study that begins with a single ascending dose evaluation in healthy volunteers followed by a multiple dose assessment in patients. The design is intended to define the highest safe and well tolerated dose, establish a robust PK and PD baseline, and generate initial patient level evidence to support dose selection and advancement into subsequent clinical development.
Phase 1
Recruiting
California Clinical Trials Medical GroupHakop Gevorkyan, MDNeutrolis
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Have you considered Naprelan clinical trials? We made a collection of clinical trials featuring Naprelan, we think they might fit your search criteria.Go to Trials
Image of Johns Hopkins Medicine in Baltimore, United States.

Embolization for Migraine

18 - 80
All Sexes
Baltimore, MD
This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into the brain's bloodstream will be reduced. The company that manufactures Onyx, Medtronic, is providing the supplies for this study. Participants will be in the study for about 8 months after enrolling, including 6 months of follow up after the procedure. The participants will be asked to complete a daily headache diary and continue the participant's regular migraine medications. Participants will also have several clinic visits and be asked to provide blood samples for research.
Waitlist Available
Has No Placebo
Johns Hopkins MedicineRisheng Xu, MD, PhDMedtronic
Image of Baylor College of Medicine/Texas Children's Hospital in Austin, United States.

Guided Imagery Therapy for Abdominal Pain

7 - 12
All Sexes
Austin, TX
Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet. Participants will complete a baseline abdominal pain and stooling diary to determine eligibility, as well as other surveys. Eligible participants will be given access to the guided imagery therapy mobile application. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out of 7 days per week for 8 weeks, in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary, along with other psychometric surveys, at the end of this intervention period. Participants will also collect another diary and surveys 3 months post-treatment.
Waitlist Available
Has No Placebo
Baylor College of Medicine/Texas Children's Hospital (+1 Sites)
Image of Weill Cornell Medical College in New York, United States.

Health Coaching for Rheumatoid Arthritis

18+
All Sexes
New York, NY
The goal of this clinical trial is to learn if peer coaching works to reduce levels of anxiety and/or depression in adults diagnosed with Rheumatoid Arthritis (RA). The main questions it aims to answer are: Do people with RA who complete the intervention with a peer coach have lower levels of anxiety and/or depression at 6 months from baseline? Do people with RA who complete the intervention with a peer coach have lower levels of anxiety and/or depression at 6 months compared to those in the control arm? Researchers will compare the peer coaching intervention to an active-control arm (where people without RA coach participants on general health and nutrition topics) to see if peer coaching works to reduce anxiety and/or depression. Participants will meet with a coach every week for 9 weeks and complete several surveys before, during and after the intervention
Recruiting
Has No Placebo
Weill Cornell Medical CollegeIris Y Navarro-Millán, MDBristol-Myers Squibb
Have you considered Naprelan clinical trials? We made a collection of clinical trials featuring Naprelan, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security